News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alnylam Pharmaceuticals Inc (Symbol: ALNY), where a total of 8,808 contracts have traded so far, representing approximately 880,800 underlying shares. That amounts to about 142.3% of ALNY's average daily trading volume over the past month of 618,805 shares. Particularly high volume was seen for the $150 strike put option expiring July 19, 2024, with 1,516 contracts trading so far today, representing approximately 151,600 underlying shares of ALNY. Below is a chart showing ALNY's trailing twelve month trading history, with the $150 strike highlighted in orange:

Merck & Co Inc (Symbol: MRK) saw options trading volume of 94,366 contracts, representing approximately 9.4 million underlying shares or approximately 123.9% of MRK's average daily trading volume over the past month, of 7.6 million shares. Especially high volume was seen for the $125 strike call option expiring June 21, 2024, with 16,761 contracts trading so far today, representing approximately 1.7 million underlying shares of MRK. Below is a chart showing MRK's trailing twelve month trading history, with the $125 strike highlighted in orange:

And Eastman Chemical Co (Symbol: EMN) options are showing a volume of 8,679 contracts thus far today. That number of contracts represents approximately 867,900 underlying shares, working out to a sizeable 105.4% of EMN's average daily trading volume over the past month, of 823,335 shares. Particularly high volume was seen for the $95 strike call option expiring June 21, 2024, with 3,690 contracts trading so far today, representing approximately 369,000 underlying shares of EMN. Below is a chart showing EMN's trailing twelve month trading history, with the $95 strike highlighted in orange:

For the various different available expirations for ALNY options, MRK options, or EMN options, visit StockOptionsChannel.com.

Also see:

ARMF Historical Stock Prices
CHIM Historical Stock Prices
TRMD Stock Predictions

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.